Skip to content
HeyJared

Hamlet BioPharma AB

Reporter · SE

Indexed articles, last 90 days
1
Latest publication
Sep 17, 2026
Outlet visibility, for Dagens industri
Top 5K sites
Earliest in this view
Sep 17, 2026

Latest articles

  1. Article · Sep 17, 2026 · Hamlet BioPharma AB (publ)

    Successful patient enrolment in HAMLET BioPharma's Phase… (opens the original)

    Excerpt · Positive tone · Swedish

    Read excerpt

    HAMLET BioPharma is proud to announce that the clinical phase of the Phase III trial has started. Patients with non-muscle invasive bladder cancer are being enrolled and treated according to the study protocol, which is approved by the European and US authorities, EMA and FDA. This remarkable milestone is reached shortly after the company communicated the successful approval process with the EMA at the end of June, the successful production of Alpha1H drug at Phase III quality and transport to t

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Not enough subject data for this period yet.

Audience

Top 5K sites

For Dagens industri, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Hamlet BioPharma AB